| Product Code: ETC9495495 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sudan Neurodegenerative Disease Market Overview |
3.1 Sudan Country Macro Economic Indicators |
3.2 Sudan Neurodegenerative Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Sudan Neurodegenerative Disease Market - Industry Life Cycle |
3.4 Sudan Neurodegenerative Disease Market - Porter's Five Forces |
3.5 Sudan Neurodegenerative Disease Market Revenues & Volume Share, By Indication Type, 2021 & 2031F |
3.6 Sudan Neurodegenerative Disease Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 Sudan Neurodegenerative Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about neurodegenerative diseases in Sudan |
4.2.2 Growing geriatric population in Sudan |
4.2.3 Technological advancements in diagnosis and treatment of neurodegenerative diseases |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas of Sudan |
4.3.2 Lack of skilled healthcare professionals specializing in neurodegenerative diseases |
4.3.3 High cost of neurodegenerative disease treatments in Sudan |
5 Sudan Neurodegenerative Disease Market Trends |
6 Sudan Neurodegenerative Disease Market, By Types |
6.1 Sudan Neurodegenerative Disease Market, By Indication Type |
6.1.1 Overview and Analysis |
6.1.2 Sudan Neurodegenerative Disease Market Revenues & Volume, By Indication Type, 2021- 2031F |
6.1.3 Sudan Neurodegenerative Disease Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.1.4 Sudan Neurodegenerative Disease Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.1.5 Sudan Neurodegenerative Disease Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.6 Sudan Neurodegenerative Disease Market Revenues & Volume, By Huntington Disease, 2021- 2031F |
6.1.7 Sudan Neurodegenerative Disease Market Revenues & Volume, By Other Indication Types, 2021- 2031F |
6.2 Sudan Neurodegenerative Disease Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Sudan Neurodegenerative Disease Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 Sudan Neurodegenerative Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.4 Sudan Neurodegenerative Disease Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F |
6.2.5 Sudan Neurodegenerative Disease Market Revenues & Volume, By Immunomodulatory Drugs, 2021- 2031F |
6.2.6 Sudan Neurodegenerative Disease Market Revenues & Volume, By Other Drug Types, 2021- 2031F |
7 Sudan Neurodegenerative Disease Market Import-Export Trade Statistics |
7.1 Sudan Neurodegenerative Disease Market Export to Major Countries |
7.2 Sudan Neurodegenerative Disease Market Imports from Major Countries |
8 Sudan Neurodegenerative Disease Market Key Performance Indicators |
8.1 Number of neurologists specializing in neurodegenerative diseases in Sudan |
8.2 Rate of adoption of new technologies for diagnosis and treatment |
8.3 Number of awareness campaigns and educational programs conducted on neurodegenerative diseases in Sudan |
9 Sudan Neurodegenerative Disease Market - Opportunity Assessment |
9.1 Sudan Neurodegenerative Disease Market Opportunity Assessment, By Indication Type, 2021 & 2031F |
9.2 Sudan Neurodegenerative Disease Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 Sudan Neurodegenerative Disease Market - Competitive Landscape |
10.1 Sudan Neurodegenerative Disease Market Revenue Share, By Companies, 2024 |
10.2 Sudan Neurodegenerative Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here